Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (9)
  • DNA/RNA Synthesis
    (4)
  • Antifolate
    (3)
  • Autophagy
    (3)
  • ADC Cytotoxin
    (2)
  • Antibacterial
    (2)
  • Dehydrogenase
    (2)
  • EGFR
    (2)
  • Microtubule Associated
    (2)
  • Others
    (7)
Filter
Search Result
Results for "

anti-neoplastic

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    26
    TargetMol | Inhibitors_Agonists
  • PROTAC Products
    1
    TargetMol | PROTAC
  • Natural Products
    2
    TargetMol | Natural_Products
  • Recombinant Protein
    4
    TargetMol | Recombinant_Protein
  • Antibody Products
    1
    TargetMol | Antibody_Products
  • Disease Modeling
    1
    TargetMol | Disease_Modeling_Products
Suramin Sodium Salt
Suramin hexasodium salt, NF-060, BAY-205
T2160129-46-4
Suramin Sodium Salt (BAY-205) is a sodium salt form of suramin, a polysulphonated naphthylurea with potential antineoplastic activity. Suramin blocks the binding of various growth factors, including insulin-like growth factor I (IGF-I), epidermal growth factor (EGF), platelet-derived growth factor (PDGF), and tumor growth factor-beta (TGF-beta), to their receptors, thereby inhibiting endothelial cell proliferation and migration. This agent also inhibits vascular endothelial growth factor (VEGF)- and basic fibroblast growth factor (bFGF)-induced angiogenesis; retroviral reverse transcriptase; uncoupling of G-proteins from receptors; topoisomerases; cellular folate transport; and steroidogenesis.
  • $35
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
SKF-96365 hydrochloride
SKF96365
T2170130495-35-1
SKF-96365 hydrochloride (SKF96365) , a SOCE inhibitor, exhibits potent anti-neoplastic activity by inducing cell-cycle arrest and apoptosis in colorectal Y cells. SKF-96365 hydrochloride can induce cytoprotective autophagy to delay apoptosis by preventing the release of cytochrome c (cyt c) from the mitochondria into the cytoplasm. Mechanistically, SKF-96365 hydrochloride treatment inhibited the calcium/calmodulin-dependent protein kinase IIγ (CaMKIIγ)/AKT signaling cascade in vitro and in vivo. Overexpression of CaMKIIγ or AKT abolished the effects of SKF-96365 on Y cells, suggesting a critical role of the CaMKIIγ/AKT signaling pathway in SFK-96365-induced biological effects. SKF-96365 hydrochloride inhibited hERG current in a concentration-dependent manner.
  • $52
In Stock
Size
QTY
TargetMol | Citations Cited
Cisplatin
cis-Diaminodichloroplatinum, CDDP
T156415663-27-1
Cisplatin (CDDP) is a chemotherapeutic agent with antitumor activity and is a classic DNA crosslinker. It inhibits DNA synthesis and induces DNA damage in cancer cells by forming DNA adducts, ultimately leading to cell death. In addition, Cisplatin can activate ferroptosis and induce autophagy. In animal studies, it is commonly used to establish models of chronic kidney injury and acute renal failure.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Dacarbazine
Imidazole Carboxamide, DTIC-Dome
T11204342-03-4
Dacarbazine (DTIC-Dome) is an antineoplastic agent. It has significant activity against melanomas.
  • $32
In Stock
Size
QTY
Mitotane
o,p'-DDD, NCI-C04933, Mitotan, 2,4′-DDD
T119953-19-0
Mitotane (NCI-C04933) is a derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.
  • $30
In Stock
Size
QTY
Methotrexate
WR19039, NCI-C04671, CL14377, Amethopterin
T148559-05-2
Methotrexate (WR19039) is a folate analog, an inhibitor of the dihydrofolate reductase DHFR. Methotrexate has antimetabolic, antitumor, and immunosuppressive activities, and is commonly used in rheumatoid arthritis and various tumors.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
Alpelisib
BYL-719
T19211217486-61-7
Alpelisib (BYL-719) is a PI3Kα inhibitor (IC50=5 nM) with selective, potent, and oral activity, inhibiting PI3Kβ γ δ with low activity (IC50=250 290 1200 nM). Alpelisib demonstrates antitumor activity and specifically targets PIK3CA mutant tumors.
  • $33
In Stock
Size
QTY
TargetMol | Citations Cited
Fursultiamine
Judolor, Diteftin, Alinamin F
T4552804-30-8
Fursultiamine (Alinamin F) is a disulfide derivative of thiamine, or an allithiamine. It has potential uses in the treatment of vitamin B1 deficiency.
  • $35
In Stock
Size
QTY
Levoleucovorin Calcium
CL307782, Calcium Levofolinate
T643180433-71-2
Levoleucovorin Calcium (CL307782), a calcium salt of the folinic acid, is used in cancer chemotherapy as an adjuvant.
  • $36
In Stock
Size
QTY
Methotrexate disodium
T80037413-34-5
Methotrexate disodium is an tetrahydrofolate dehydrogenase inhibitor
  • $34
In Stock
Size
QTY
Orelabrutinib
ICP-022
T123171655504-04-3
Orelabrutinib (ICP-022) is an orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK).
  • $83
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Pemigatinib
INCB054828
T124011513857-77-6
Pemigatinib (INCB054828) is an orally active, selective inhibitor of FGFR, with IC50 values of 0.4 nM for FGFR1, 0.5 nM for FGFR2, 1.2 nM for FGFR3, and 30 nM for FGFR4.
  • $41
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
Crolibulin
EPC2407
T150121000852-17-4
Crolibulin (EPC2407) is an inhibitor of small molecule tubulin polymerization.
  • $58
In Stock
Size
QTY
Estramustine
NSC-89201, NSC89201, NSC 89201, LEO-275, LEO275, LEO 275
T206812998-57-4
Estramustine (LEO-275) is a nitrogen mustard linked to estradiol, usually as phosphate. Estramustine has been used to treat prostatic neoplasms; also has radiation protective properties. Estramustine is selectively taken up by prostate cells and exerts antineoplastic effects by interfering with microtubule of dynamics and by reducing plasma levels of testosterone.
  • $39
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Almonertinib
HS-10296
T54621899921-05-1
Almonertinib (HS-10296) is an inhibitor specifically targeting EGFR activation mutations and the resistant EGFR T790M mutation, exhibiting limited activity against wild-type EGFR.
  • $91
In Stock
Size
QTY
TargetMol | Citations Cited
Almonertinib hydrochloride
HS-10296 hydrochloride
T56752134096-03-8
Almonertinib hydrochloride (HS-10296 hydrochloride) is a small molecule inhibitor of EGFR-activating mutations and T790M-resistant mutation with limited activity against wild-type EGFR.
  • $93
In Stock
Size
QTY
Bexarotene
Targretin, Ro 26-4455, LGD1069
T6410153559-49-0
Bexarotene (LGD1069) is a retinoid analogue that is used to treat the skin manifestations of cutaneous T cell lymphoma (CTCL).
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
Aniline mustard
NSC-18429, Mesylerythrol, Lymphocin
T19736553-27-5
Aniline mustard (Mesylerythrol) is alkylating mustard with anti-neoplastic activity.
  • $29
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Taurolidine
T753319388-87-5
Taurolidine is a synthetic taurine analog with antimicrobial and anti-neoplastic actions. It displays broad bactericidal and fungicidal activity.
  • $30
In Stock
Size
QTY
CMLD012072
T108472368900-33-6
CMLD012072 is a potent eukaryotic initiation factor 4A (eIF4A) inhibitor with potent anti-neoplastic activity. It can induce RNA clamping of eIF4A1 and eIF4A2.
  • $1,520
6-8 weeks
Size
QTY
Lobaplatin
D-19466
T15771135558-11-1
Lobaplatin (D-19466) (D-19466) is a diastereometric mixture of platinum(II) complexe. Lobaplatin (D-19466) is a third-generation platinum anti-neoplastic agent which shows activity for a variety of tumour types and is a promising antitumour chemotherapeutic agent[1][2]. It is a platinum complex with DNA alkylating activity.
  • $89
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Didemnin C
T2532877327-06-1
Didemnin C is used as an anti-neoplastic agent.
  • $1,520
Backorder
Size
QTY
Bimolane
T348174550-97-3
Bimolane is a topoisomerase II inhibitor.
  • $35
In Stock
Size
QTY
Ethyl trans-caffeate
Ethyl caffeate, Caffeic Acid Ethyl Ester
T3S001366648-50-8
1. Ethyl trans-caffeate (Caffeic Acid Ethyl Ester) has anti-inflammatory activity. 2. Ethyl trans-caffeate may as a promising natural compound for future application in chronic liver disease. 3. Ethyl trans-caffeate is a potent chemopreventive compound against skin carcinogenesis caused by solar UV exposure. 4. Ethyl trans-caffeate is the high-resolution structures of representative inhibitors in complex with human pancreatic α-amylase. 5. Ethyl trans-caffeate strongly inhibits neoplastic transformation of JB6 Cl41 cells without toxicity. PI3K, ERK1/2, and p38 kinase activities were suppressed by direct binding with HOEC in vitro.
  • $50
Backorder
Size
QTY
TargetMol | Citations Cited